Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.38 USD | -0.16% | -2.60% | -.--% |
05-14 | Metagenomi, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-07 | HC Wainwright Starts Metagenomi With Buy Rating, $10 Price Target | MT |
Sales 2024 * | 39.33M 53.59M | Sales 2025 * | 31.45M 42.85M | Capitalization | 239M 326M |
---|---|---|---|---|---|
Net income 2024 * | -112M -153M | Net income 2025 * | -144M -196M | EV / Sales 2024 * | 6.08 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 7.6 x |
P/E ratio 2024 * |
-1.9
x | P/E ratio 2025 * |
-1.96
x | Employees | 237 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.51% |
1 day | -0.16% | ||
1 week | -2.60% | ||
1 month | +3.40% | ||
3 months | -46.83% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 6.38 | -0.16% | 24,960 |
24-05-30 | 6.39 | -0.16% | 22,139 |
24-05-29 | 6.4 | -0.31% | 30,735 |
24-05-28 | 6.42 | -1.98% | 37,985 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-.--% | 239M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- MGX Stock